Area
Facultad de Ciencias de la Salud
Department
Physiotherapy
Email:
garazi.aldanondo@deusto.esArticles in Scientific Journals
Pharmacokinetic evaluation of new drugs using a multi-labelling approach and PET imaging: application to a drug candidate with potential application in neuromuscular disorders / Biomedicines
Aldanondo Aristizabal, Garazi
ISBNAR: 2227-9059 / Volume: 253 / Journal number: 11 / Start page: 1 / End page: 23 / Date: 2023
Discovery of a novel family of FKBP12 "reshapers" and their use as calcium modulators in skeletal muscle under nitro-oxidative stress / European Journal of Medicinal Chemistry
Aldanondo Aristizabal, Garazi
ISBNAR: 0223-5234 / Volume: 213 / Journal number: 113160 / Date: 2021
Monitoring disease activity noninvasively in the mdx model of Duchenne muscular dystrophy / Proceedings of the National Academy of Sciences of the United States of America
Aldanondo Aristizabal, Garazi
ISBNAR: 0027-8424 / Volume: 115 / Journal number: 30 / Start page: 7741 / End page: 7746 / Date: 2018
Calpain 3 deficiency affects SERCA expression and function in the skeletal muscle / Expert Reviews in Molecular Medicine
Aldanondo Aristizabal, Garazi
ISBNAR: 1462-3994 / Volume: 18 / Journal number: E7 / Date: 2016
Chapters of Books
A novel functional in vitro model that recapitulates human muscle disorders / Muscle Cell and Tissue
Aldanondo Aristizabal, Garazi
ISBNCO: 978-953-51-6092-2 / Date: 2018
Novel RyR modulators for dystrophinopathies
Aldanondo Aristizabal, Garazi
Congress name: Novel RyR modulators for dystrophinopathies / Publication name: Novel RyR modulators for dystrophinopathies / Start date: 2016/09/02 / End date: 2016/09/06
Effect of a novel modulator of ryanodine receptors in mouse and human models of Duchenne muscular dystrophy
Aldanondo Aristizabal, Garazi
Congress name: Effect of a novel modulator of ryanodine receptors in mouse and human models of Duchenne muscular dystrophy / Publication name: Effect of a novel modulator of ryanodine receptors in mouse and human models of Duchenne muscular dystrophy / Date: 2016/06/27
Alteration of calcium handling proteins in human in vitro models of limb girdle muscular dystrophy type 2A (LGMD2A).
Aldanondo Aristizabal, Garazi
Congress name: Alteration of calcium handling proteins in human in vitro models of limb girdle muscular dystrophy type 2A (LGMD2A). / Publication name: Alteration of calcium handling proteins in human in vitro models of limb girdle muscular dystrophy type 2A (LGMD2A). / Date: 2016/06/27
Alteration of calcium homeostasis in human in vitro models of limb girdle muscular dystrophy type 2A (LGMD2A).
Aldanondo Aristizabal, Garazi
Congress name: Alteration of calcium homeostasis in human in vitro models of limb girdle muscular dystrophy type 2A (LGMD2A). / Publication name: Alteration of calcium homeostasis in human in vitro models of limb girdle muscular dystrophy type 2A (LGMD2A). / Start date: 2016/03/14 / End date: 2016/03/18
Treatment of mdx mice with novel RyR1 stabilizers ameliorate muscular dystrophy progression.
Aldanondo Aristizabal, Garazi
Congress name: Treatment of mdx mice with novel RyR1 stabilizers ameliorate muscular dystrophy progression. / Publication name: Treatment of mdx mice with novel RyR1 stabilizers ameliorate muscular dystrophy progression. / Start date: 2015/09/21 / End date: 2015/09/25
Effect of a novel modulator of ryanodine receptor 1 in the mdx mouse model of Duchenne muscular dystrophy.
Aldanondo Aristizabal, Garazi
Congress name: Effect of a novel modulator of ryanodine receptor 1 in the mdx mouse model of Duchenne muscular dystrophy. / Publication name: Effect of a novel modulator of ryanodine receptor 1 in the mdx mouse model of Duchenne muscular dystrophy. / Date: 2014/07/09
Altered SERCA expression and function in limb girdle muscular dystrophy 2A.
Aldanondo Aristizabal, Garazi
Congress name: Altered SERCA expression and function in limb girdle muscular dystrophy 2A. / Publication name: Altered SERCA expression and function in limb girdle muscular dystrophy 2A. / Date: 2014/07/09
New evidence for calcium mishandling in human Calpain 3 deficient myotubes.
Aldanondo Aristizabal, Garazi
Congress name: New evidence for calcium mishandling in human Calpain 3 deficient myotubes. / Publication name: New evidence for calcium mishandling in human Calpain 3 deficient myotubes. / Start date: 2013/09/21 / End date: 2013/09/25
Effect of calpain 3 defficiency on calcium homeostasis.
Aldanondo Aristizabal, Garazi
Congress name: Effect of calpain 3 defficiency on calcium homeostasis. / Publication name: Effect of calpain 3 defficiency on calcium homeostasis. / Date: 2013/07/08
Preclinical characterization of ryanodine receptor stabilizers in muscular dystrophies.
Aldanondo Aristizabal, Garazi
Congress name: Preclinical characterization of ryanodine receptor stabilizers in muscular dystrophies. / Publication name: Preclinical characterization of ryanodine receptor stabilizers in muscular dystrophies. / Start date: 2013/04/16 / End date: 2013/04/17
Efecto de nuevos moduladores del receptor de rianodina en modelos animales de distrofia muscular.
Aldanondo Aristizabal, Garazi
Congress name: Efecto de nuevos moduladores del receptor de rianodina en modelos animales de distrofia muscular. / Country: España / Publication name: Efecto de nuevos moduladores del receptor de rianodina en modelos animales de distrofia muscular. / Start date: 2012/12/12 / End date: 2012/12/15
Effect of S107 on human primary and fibroblast-derived myotubes
Aldanondo Aristizabal, Garazi
Congress name: Effect of S107 on human primary and fibroblast-derived myotubes / Publication name: Effect of S107 on human primary and fibroblast-derived myotubes / Start date: 2012/09/01 / End date: 2012/09/05